John M. Centanni

John M. Centanni has over 20 years of experience in the field of regulatory affairs and quality assurance. John M. began their career in 1999 as a Senior Scientist at Promega Corporation. In 2001, they became the Director of Regulatory Affairs & Quality Assurance at Stratatech Corporation. In 2010, they took on the role of Regulatory Affairs Support at Waisman Biomanufacturing and Director Regulatory Compliance at the UW-Madison Radiopharmaceutical Production Facility. John M. also became the Director of the ICTR IND/IDE Consultation Service Team in 2011. In 2013, they were a Faculty Associate for the Master of Science in Biotechnology Program. From 2016 to 2019, they held the role of Head of Regulatory Affairs- Biologics at AxoGen, Inc., followed by VP of Regulatory Affairs at Neurona Therapeutics from 2019 to 2020. Currently, they are a Principal Consultant, Global Regulatory Affairs at Cardinal Health and will soon be VP Regulatory Affairs at Coya Therapeutics, Inc. starting in 2022.

John M. Centanni received their B.S. in Biology from the University of Wisconsin Oshkosh in 1987 and their M.S. in BioMedical Sciences- Molecular & Cellular Biology from Hood College in 1996.